sources: 15109

This table contains all the sources for our datasets. The description column contains JSON encoded as text that contains useful additional fields like a longer descriptive text "additionalInfo".

Data license: CC-BY

This data as json

id name description createdAt updatedAt datasetId additionalInfo link dataPublishedBy
15109 Share of Public Pharmaceutical Expenditure in Total Pharmaceutical Expenditure (%) 
{
    "link": "http://apps.who.int/gho/data/node.home",
    "retrievedDate": "23-March-18",
    "additionalInfo": "Indicator name\nShare of Public Pharmaceutical Expenditure in Total Pharmaceutical Expenditure (%) \n\nName abbreviated\nPPE/TPE\n\nData Type Representation\nPercent\n\nTopic\nHealth systems resources\n\nISO Health Indicators Framework\n\n    \n\nRationale\n\n    \n\nDefinition\nThe share of public expenditure on pharmaceuticals incurred by public funds of total pharmaceutical expenditure. Public funds are state, regional and local government bodies and social security schemes. \n\nAssociated terms\nTPE : Pharmaceuticals, medicinal chemicals and botanical products for health uses, prescribed or not. Comprises to the extent possible outlays during episodes of hospital care and in out-patients (intermediate consumption in national income & product accounts), as well as OTC sales. (NHA)\n\nPreferred data sources\nSpecial studies\n\nPreferred data sources\nNational Health Accounts\n\nOther possible data sources\n\n    \n\nMethod of measurement\n\n    \n\nMethod of estimation\n\u00a0\nData as provided by countries. No estimation was made.\n\nM&E Framework\nInput\n\nMethod of estimation of global and regional aggregates\nRegional and global synthesis reports based on Pharmaceutical Country Profile submissions.\n\nDisaggregation\nWealth\n\nUnit of Measure\nN/A\n\nUnit Multiplier\nNot Applicable\n\nExpected frequency of data dissemination\nEvery 3-5 years\n\nExpected frequency of data collection\nEvery 3-5 years\n\nLimitations\n\n    \n\nLinks\nPharmaceuticial Country Profiles\n\nComments\nQ: 2.01.16C\n\nContact Person\n\n      \n\n",
    "dataPublishedBy": "World Health Organization Global Health Observatory (GHO)",
    "dataPublisherSource": null
}
 2018-03-23 12:43:30 2018-03-23 12:43:30 2678 Indicator name Share of Public Pharmaceutical Expenditure in Total Pharmaceutical Expenditure (%) Name abbreviated PPE/TPE Data Type Representation Percent Topic Health systems resources ISO Health Indicators Framework Rationale Definition The share of public expenditure on pharmaceuticals incurred by public funds of total pharmaceutical expenditure. Public funds are state, regional and local government bodies and social security schemes. Associated terms TPE : Pharmaceuticals, medicinal chemicals and botanical products for health uses, prescribed or not. Comprises to the extent possible outlays during episodes of hospital care and in out-patients (intermediate consumption in national income & product accounts), as well as OTC sales. (NHA) Preferred data sources Special studies Preferred data sources National Health Accounts Other possible data sources Method of measurement Method of estimation   Data as provided by countries. No estimation was made. M&E Framework Input Method of estimation of global and regional aggregates Regional and global synthesis reports based on Pharmaceutical Country Profile submissions. Disaggregation Wealth Unit of Measure N/A Unit Multiplier Not Applicable Expected frequency of data dissemination Every 3-5 years Expected frequency of data collection Every 3-5 years Limitations Links Pharmaceuticial Country Profiles Comments Q: 2.01.16C Contact Person http://apps.who.int/gho/data/node.home World Health Organization Global Health Observatory (GHO)

Links from other tables